These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24372836)

  • 1. Concordance of c-kit mutational status in matched primary and metastatic cutaneous canine mast cell tumors at baseline.
    Marconato L; Zorzan E; Giantin M; Di Palma S; Cancedda S; Dacasto M
    J Vet Intern Med; 2014; 28(2):547-53. PubMed ID: 24372836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
    London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
    Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing.
    Vozdova M; Kubickova S; Pal K; Fröhlich J; Fictum P; Rubes J
    Vet Comp Oncol; 2020 Dec; 18(4):509-518. PubMed ID: 31999054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
    Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
    BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
    Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
    Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an intron deletion in the c-kit gene of canine mast cell tumors.
    Reguera MJ; Ferrer L; Rabanal RM
    Am J Vet Res; 2002 Sep; 63(9):1257-61. PubMed ID: 12224856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumors.
    Pryer NK; Lee LB; Zadovaskaya R; Yu X; Sukbuntherng J; Cherrington JM; London CA
    Clin Cancer Res; 2003 Nov; 9(15):5729-34. PubMed ID: 14654558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors.
    Webster JD; Yuzbasiyan-Gurkan V; Kaneene JB; Miller R; Resau JH; Kiupel M
    Neoplasia; 2006 Feb; 8(2):104-11. PubMed ID: 16611403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of mutations in the c-kit gene of 32 dogs with mastocytoma.
    Riva F; Brizzola S; Stefanello D; Crema S; Turin L
    J Vet Diagn Invest; 2005 Jul; 17(4):385-8. PubMed ID: 16131001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs.
    Downing S; Chien MB; Kass PH; Moore PE; London CA
    Am J Vet Res; 2002 Dec; 63(12):1718-23. PubMed ID: 12492288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs.
    Zemke D; Yamini B; Yuzbasiyan-Gurkan V
    Vet Pathol; 2002 Sep; 39(5):529-35. PubMed ID: 12243462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
    Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
    Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs.
    Zavodovskaya R; Chien MB; London CA
    J Vet Intern Med; 2004; 18(6):915-7. PubMed ID: 15638281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
    Gentilini F; Turba ME; Dally C; Takanosu M; Kurita S; Bonkobara M
    BMC Vet Res; 2020 Feb; 16(1):64. PubMed ID: 32075643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weishaar's classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor.
    Stefanello D; Gariboldi EM; Boracchi P; Ferrari R; Ubiali A; De Zani D; Zani DD; Grieco V; Giudice C; Recordati C; Caniatti M; Auletta L; Chiti LE
    J Vet Intern Med; 2024; 38(3):1675-1685. PubMed ID: 38426589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours.
    Gentilini F; Mantovani V; Turba ME
    Vet Comp Oncol; 2015 Sep; 13(3):218-28. PubMed ID: 23654224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
    Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
    Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine.
    Weishaar KM; Ehrhart EJ; Avery AC; Charles JB; Elmslie RE; Vail DM; London CA; Clifford CA; Eickhoff JC; Thamm DH
    J Vet Intern Med; 2018 Jan; 32(1):394-405. PubMed ID: 29194765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine mast cell tumors express stem cell factor receptor.
    Reguera MJ; Rabanal RM; Puigdemont A; Ferrer L
    Am J Dermatopathol; 2000 Feb; 22(1):49-54. PubMed ID: 10698217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.